Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Multiplex Biomarker Imaging Market Snapshot (2022 to 2029)

[280 Pages Report] The global Multiplex Biomarker Imaging Market was valued at US$ 422.1 Million in 2021 and is expected to reach US$ 1,041.7 Million by 2029, finds Future Market Insights (FMI) in a recent market survey.

Data Points Market Insights
Market Value 2022 USD 475.2 Million
Market Value 2029 USD 1,041.7 Million
CAGR 2022 to 2029 11.9%
Key Players The key players are PerkinElmer Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Abcam plc., Merck KGaA, Illumina Inc., Leica Biosystems Nussloch GmbH (Danaher Corporation), Ventana Medical Systems, Inc. (A F. Hoffmann-La Roche AG Subsidiary), Aushon BioSystems Ltd., MicroConstants, Inc., and ToposNomos Ltd. (TNL)
Share of Top 5 Countries            70.7%

The growing prevalence of tumors and cancer among populations around the world and increasing demand for more effective treatment and medicine for different types of cancer are primary factors fueling the multiplex biomarker imaging market.

In addition, the growing adoption of personalized medicine is expected to drive the growth of the multiplex biomarker imaging market. Moreover, the availability of technologically advanced instruments is likely to add to the market development.

The multiplex biomarker imaging market holds nearly 1.6% market value share of the US$ 31 Billion biomarkers market in 2021. An increase in the production base of multispectral imaging devices that could provide multiplexing is expected to fuel the revenue growth of device manufacturers.

Leading manufacturers of multiplex biomarker imaging are also focusing on collaborations with laboratories and biopharmaceutical companies in order to expand their sales presence.  

Driven by this, sales of multiplex biomarker imaging are expected to rise at an 11.9% CAGR through 2029.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

How The Market Progressed Till June 2022?

Particulars Details
H1, 2021 11.88%
H1, 2022 Projected 11.86%
H1, 2022 Outlook 11.76%
BPS Change - H1, 2022 (O) - H1, 2022 (P) (-) 10 ↓
BPS Change - H1, 2022 (O) - H1, 2021 (-) 12 ↓

The multiplex biomarker imaging market is subject to influence by the rising inpatient base with tumors, and technological developments by the impact of macro and industry factors. FMI presents a comparative analysis of the market growth rates and development prospects in the global multiplex biomarker imaging market.

According to Future Market Insight analysis, the multiplex biomarker imaging market will drop by 12 Basis Point Share (BPS) in H1-2022 (O) compared to H1-2021. The preservation of discrete microenvironment morphology may be compromised in multiplex biomarker imaging due to lack of resolution or because of sampling time, it is difficult to preserve the immunolabeling with morphology.

This is the major reason for the drop in BPS attributed to the decline in shares. The H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 10 BPS.

Despite the factors, some plus points stay ahead for the industry including technological advancements such as faster scanning time and higher sensitivity and emerging players entering into supply and distributor partnerships to expand their market reach.

2012 to 2021 Multiplex Biomarker Imaging Market Demand Outlook Compared to 2022 to 2029 Forecast

Sales of multiplex biomarker imaging grew at a CAGR of 13.5% between 2012 and 2021.

The multiplex biomarker imaging market is expected to show rapid growth owing to the increasing prevalence of chronic diseases, rising adoption of personalized medicine, and a broad range of benefits of multiplex imaging over traditional imaging.

Multiplex Biomarker Imaging Market

In addition, the high prevalence of cardiac and cancer problems, advancements in biomarkers, and increased application are the key factors contributing to market development. The surge in cancer cases worldwide has led to an increase in the use of biomarkers with the development of technology. As per the WCRF (World Cancer Research Fund International), about 18 million cases were there across the world in 2020. Also, the global burden of cancer cure and prevention is the chief concern for pharmaceutical and government companies.

Considering this, FMI expects the global multiplex biomarker imaging market to grow at a CAGR of 11.9% through 2029.

Which Factors Are Restraining Demand for Multiplex Biomarker Imaging?

The complexity of the process and unclear regulatory guidance on the commercial sale of digital pathology imaging products are anticipated to hamper the multiplex biomarker imaging market growth. There is unclear regulatory control on the commercial diagnostic use of whole slide imaging (WSI) products comprising multiplex biomarker imaging systems.

In addition, a lack of awareness regarding multiplex biomarker imaging and cloud-enabled technologies, especially in developing countries, is restraining the growth of the market. Also, the high cost of multiplex biomarker imaging devices is prohibiting the adoption of these devices in research laboratories dealing with cancer research.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What is the Impact of the COVID-19 Crisis on the Multiplex Biomarker Imaging Market?

The coronavirus continues its march around the globe, disrupting nearly every business around the world. The market observed a huge slowdown in its growth due to the spread of the Covid-19 pandemic worldwide.

As a result of pandemic-related lockdowns in different countries and disruptions in the supply chain of medical equipment, the multiplex biomarker imaging market witnessed a drop during the lockdown period.

Also, the manufacturers encountered several operational challenges that initially hampered their business activities during the lockdown. Ultimately, with the relaxation of the lockdown and the exceptional demand for diagnosis, the sales of multiple companies have grown positively. But, in the case of the multiplex biomarker imaging market, as these are playing a vital role in the development of therapies for chronic diseases, where pharmaceutical and government industries are expected to spend a lot, the market is expected to boost during the forecast period.

Country-wise Insights

What Makes the USA a Large Market for Multiplex Biomarker Imaging?

The USA is estimated to account for around 91.3% of the North American multiplex biomarker imaging market in 2022.  

The growing prevalence of chronic diseases, like cancer, rising demand for personalized and targeted medicine, favorable government initiatives, and growing aging population are the key factors contributing to the growth of the market in the USA The development can also be due to the availability of sophisticated diagnostics laboratories and great adoption rate of novel assay technologies. In addition, nearly every pharmaceutical manufacturer has been developing molecular biomarker products, either through different ventures or partnerships.

Why is Germany Considered a Lucrative Multiplex Biomarker Imaging Market?

Germany is estimated to account for 20.2% of the Europe multiplex biomarker imaging market in Europe in 2022.

The growth of the market in Germany is because of the growing demand for automated equipment and the commercialization of multipurpose instruments with cloud-enabled technologies in many labs and research facilities. In addition, growing cancer research funding by biotech and pharmaceutical companies is leading to increased biomarker discovery which is contributing to market development. Also, the growing prevalence of cancer is resulting in greater adoption of these biomarkers for early diagnosis which is increasing the demand for the market in Germany.

What are the Factors Fueling the Demand for Multiplex Biomarker Imaging in Japan?

The multiplex biomarker imaging market in Japan is estimated to be worth US$ 21.8 Million in 2022 in the global market.

The major factors responsible for the development of the market in Japan are the existence of a huge patient pool, rising focus on efficient and rapid diagnostics because of the rising incidence of chronic diseases, the presence of manufacturers in Japan, and increasing investment to improve robust healthcare facilities.

Moreover, rising awareness concerning the significance of biomarkers in clinical diagnostics, developments in drug discovery and manufacturing processes, and growing clinical studies to understand the role of biomarkers in the prognosis and diagnosis of complex diseases is expected to have a favorable effect on the growth of the market.

How will the Multiplex Biomarker Imaging Market Expand across India?

Demand for multiplex biomarker imaging in India is expected to rise at around 6.6% CAGR over the forecast period.

Increased focus on cancer research and increased demand for testing of non-small cell lung cancer are primary factors leading to the growth of the market in India. There is an increased focus on cancer research in India. Also, there is increased awareness for better diagnosis and focus on the establishment of better research facilities in the country. Thus, increased access to better healthcare and diagnostic infrastructure and the establishment of translational laboratories are factors fueling the demand for better imaging systems.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Demand for Instruments to continue gaining Traction

By component type, the instruments segment is anticipated to hold the maximum share of 73.9% in 2022, expanding at a rate of nearly 11.8% during the forecast period.

The advantages offered by instruments like reliability, high image quality, and speed for entire slide imaging are encouraging the companies towards this instrument. Moreover, assessable pathology imaging systems, even though in their nascent stage, are adding to the potential sales forecasts for market players. Growing funding to develop advanced clinical and research laboratories has led to an increase in the purchase of these instruments, which is anticipated to contribute to the development of the segment.

Why Immunohistochemistry (IHC) Assay will hold the most of the market share?

By imaging technique, Immunohistochemistry (IHC) Assay will lead the market and is projected to account for 66.5% of the total market revenue share in 2022.

IHC is a histological method for identifying and localizing proteins in tissue specimens. This assay identifies some biomarkers such as oxidative stress, inflammation, tumors, and other diseases which assist in the diagnosis of complex diseases such as cancer using advanced methods. Thus, considering efficiency in regard to accuracy and processing time during the detection of target proteins in tissue specimens, immunohistochemistry (IHC) assays are expected to lead the market over the forecast period.

Which application is most sought-after over the forecast period?

By application, research will be the most sought-after application and is projected to account for 86.5% of the total market revenue share in 2022.

Biomarkers are vital in medicine and play a significant role in research activities such as drug discovery and development. These can determine drug efficacy at a rapid pace in comparison to traditional clinical endpoints and are expected to fuel product development for serious disease indications. Thus, good success rates of biomarkers in drug discovery are increasing their application in research, which in turn is leading to segment growth.

Why Translational Laboratories projected maximum Growth in the Multiplex Biomarker Imaging Market?

By end user, the translational laboratories segment is anticipated to hold the maximum share of 47.8% in 2022, expanding at a rapid rate of 15.3% CAGR during the forecast period.

Multiplex Biomarker Imaging is utilized in translation laboratories as they offer a high-resolution methodology for creating immunohistochemistry images and precise scores of biomarkers. This method also aids to speed up the procedure by decreasing the number of slides needed per marker, which leads to time-saving while performing analysis.

Competitive Landscape

Companies operating in the Multiplex Biomarker Imaging market are moderately competitive by nature, with a presence of few players. These players are involved in a number of strategic alliances. The product launch and acquisition accelerate the manufacturer’s strategy to capitalize on the market share and capture a significant share of the market. Some of the recent instances include:

  • In April 2021, Abcam, formerly QIAGEN (Suzhou) Translational Medicine Co., Ltd., a company dedicated to developing companion diagnostics and precision medicine, announced the extension of their strategic partnership to include the co-development and commercialization of key companion and in vitro diagnostic kits for MEDx to supply to the Chinese market.

Scope of the Report

Attribute Details
Forecast Period 2012 to 2021
Historical Data Available for 2022 to 2029
Market Analysis USD Million for Value and Units for Volume
Key Countries Covered The USA, Canada, Brazil, Mexico, Germany, Argentina, The UK, Germany, France, Italy, Spain, Nordic, Benelux, Russia, Poland, China, Japan, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, South Africa
Key Segments Covered Component Type, Imaging Technique, Application, End User, and Region
Key Companies Profiled
  • PerkinElmer Inc.
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Abcam plc.
  • Merck KGaA
  • Illumina Inc.
  • Leica Biosystems Nussloch GmbH (Danaher Corporation)
  • Ventana Medical Systems, Inc. (A F. Hoffmann-La Roche AG Subsidiary)
  • Aushon BioSystems Ltd.
  • MicroConstants, Inc.
  • ToposNomos Ltd. (TNL)
Report Coverage Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing Available upon Request

Multiplex Biomarker Imaging Market by Category

By Component Type:

  • Instruments
    • Quantitative Pathology Imaging System
    • Immunofluorescence
    • Multispectral Imaging System
    • Toponome Imaging System
  • Software
  • Services
    • Installation and Integration Services
    • Maintenance Services

By Imaging Technique:

  • Immunohistochemistry (IHC) Assay
  • Fluorescent In Situ Hybridization (FISH) Assay
  • Tissue Microarray (TMA) Assay

By Application:

  • Research
  • Clinical Diagnostics

By End User:

  • Translation Laboratories
  • Biopharmaceutical Companies
  • Academic Institutes

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Japan
  • Middle East & Africa (MEA)

Frequently Asked Questions

How much is the Multiplex Biomarker Imaging market currently worth?

The global multiplex biomarker imaging market is worth US$ 422.1 Million in 2021 and is set to expand 2.2X over the forecasted years owing to the rising cancer research and growing demand for personalized medicine.

What was historic market CAGR?

The sales of Multiplex Biomarker Imaging in the market have grown at a CAGR of nearly 13.5% between 2012 and 2021. Increasing prevalence of chronic diseases and development in imaging assays is responsible for growth over the years.

What will be demand outlook/sales forecast of Multiplex Biomarker Imaging market?

The multiplex biomarker imaging market is expected to reach US$ 1,041.7 Million by the end of 2029 with sales revenue expected to register a CAGR of 11.9% over the forecast period.

Which is the most lucrative market for Multiplex Biomarker Imaging market?

North America currently holds the largest market share of around 57.0% in 2022 in the multiplex biomarker imaging market globally with the USA being the leading contributor with a market value of over US$ 247.3 Million in the North America market in 2022.

At what percentage Multiplex Biomarker Imaging market is expected to register growth in Western Europe?

The demand for the multiplex biomarker imaging market is expected to register growth in Western Europe at a rate of 11.3% CAGR during the forecast period.

How likely is the Multiplex Biomarker Imaging market to grow in Japan?

The Multiplex Biomarker Imaging in Japan is likely to observe growth with an impressive CAGR of 11.7% during the forecast period. The major factors responsible for the development of the market in Japan are the existence of a huge patient pool, rising focus on efficient and rapid diagnostics because of the rising incidence of chronic diseases, the presence of manufacturers in Japan, and increasing investment to improve robust healthcare facilities.

What are key trends driving sales of Multiplex Biomarker Imaging?

Growing adoption of IHC processes in immunofluorescence imaging and rising demand for large data set analysis are key trends driving sales of multiplex biomarker imaging market across the globe.

What are the key market statistics in India and China?

China’s Multiplex Biomarker Imaging market is offering lucrative growth opportunities and is expected to exhibit healthy growth of 12.0% CAGR during the forecast period. India's market is expected to exhibit healthy growth of 6.6% CAGR during the forecast period.

What are the top 5 countries driving demand for Multiplex Biomarker Imaging market?

The USA, Germany, Canada, Japan, and the UK are the top 5 countries that are driving the demand for the multiplex biomarker imaging market.

Which are leading companies of Multiplex Biomarker Imaging market ?

Leading companies of multiplex biomarker imaging are PerkinElmer Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Abcam plc., Merck KGaA, Illumina Inc., Leica Biosystems Nussloch GmbH (Danaher Corporation), Ventana Medical Systems, Inc. (A F. Hoffmann-La Roche AG Subsidiary), Aushon BioSystems Ltd., MicroConstants, Inc., and ToposNomos Ltd. (TNL)

Table of Content

1. Executive Summary | Multiplex Biomarker Imaging Market

    1.1. Market Overview

    1.2. Market Analysis

    1.3. FMI Analysis and Recommendations

    1.4. Wheel of Fortune

2. Market Introduction

    2.1. Market Taxonomy

    2.2. Market Definition

3. Market View Point

    3.1. Macro-Economic Factors

    3.2. Opportunity Analysis

    3.3. Trends

    3.4. Restraints

    3.5. Pricing Analysis 2021 to 2029

4. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2029

    4.1. Introduction

    4.2. Regional Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Trends

    4.3. Historical Market Size (US$ Million) Analysis By Country, 2012 to 2021

        4.3.1. The USA

        4.3.2. Canada

    4.4. Market Size (US$ Million) Forecast By Country, 2022 to 2029

        4.4.1. The USA

        4.4.2. Canada

    4.5. Historical Market Size (US$ Million) and Volume Analysis By Component Type, 2012 to 2021

        4.5.1. Instruments

            4.5.1.1. Quantitative Pathology Imaging System

            4.5.1.2. Immunofluorescence Slide Scanner

            4.5.1.3. Multispectral Imaging Systems

            4.5.1.4. Toponome imaging System

        4.5.2. Software

        4.5.3. Services

            4.5.3.1. Installation & Integration Services

            4.5.3.2. Maintenance Service

    4.6. Market Size (US$ Million) and Volume Forecast By Component Type, 2022 to 2029

        4.6.1. Instruments

            4.6.1.1. Quantitative Pathology Imaging System

            4.6.1.2. Immunofluorescence Slide Scanner

            4.6.1.3. Multispectral Imaging Systems

            4.6.1.4. Toponome imaging System

        4.6.2. Software

        4.6.3. Services

            4.6.3.1. Installation & Integration Services

            4.6.3.2. Maintenance Service

    4.7. Historical Market Size (US$ Million) Analysis by Imaging Technique, 2012 to 2021

        4.7.1. Immunohistochemistry (IHC) Assay

        4.7.2. Fluorescent In Situ Hybridization (FISH) Assay

        4.7.3. Tissue Microarray (TMA) Assay

    4.8. Market Size (US$ Million) Forecast, by Imaging Technique, 2022 to 2029

        4.8.1. Immunohistochemistry (IHC) Assay

        4.8.2. Fluorescent In Situ Hybridization (FISH) Assay

        4.8.3. Tissue Microarray (TMA) Assay

    4.9. Historical Market Size (US$ Million) Analysis by Application, 2012 to 2021

        4.9.1. Research

        4.9.2. Clinical Diagnostics

    4.10. Market Size (US$ Million) Forecast, by Application, 2022 to 2029

        4.10.1. Research

        4.10.2. Clinical Diagnostics

    4.11. Historical Market Size (US$ Million) Analysis by Application, 2012 to 2021

        4.11.1. Translational Laboratories

        4.11.2. Biopharmaceutical Companies

        4.11.3. Academic Institutes

    4.12. Market Size (US$ Million) Forecast, by Application, 2022 to 2029

        4.12.1. Translational Laboratories

        4.12.2. Biopharmaceutical Companies

        4.12.3. Academic Institutes

    4.13. Drivers and Restraints: Impact Analysis

    4.14. Market Attractiveness Analysis

        4.14.1. By Country

        4.14.2. By Component Type

        4.14.3. By Imaging Technique

        4.14.4. Application

        4.14.5. End User

    4.15. Key Representative Market Presence (Intensity Map)

5. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2029

    5.1. Introduction

    5.2. Regional Market Dynamics

        5.2.1. Drivers

        5.2.2. Restraints

        5.2.3. Trends

    5.3. Historical Market Size (US$ Million)  Analysis By Country, 2012 to 2021

        5.3.1. Brazil

        5.3.2. Mexico

        5.3.3. Argentina

        5.3.4. Rest of  Latin America

    5.4. Market Size (US$ Million) Forecast By Country, 2022 to 2029

        5.4.1. Brazil

        5.4.2. Mexico

        5.4.3. Argentina

        5.4.4. Rest of  Latin America

    5.5. Historical Market Size (US$ Million) and Volume Analysis By Component Type, 2012 to 2021

        5.5.1. Instruments

            5.5.1.1. Quantitative Pathology Imaging System

            5.5.1.2. Immunofluorescence Slide Scanner

            5.5.1.3. Multispectral Imaging Systems

            5.5.1.4. Toponome imaging System

        5.5.2. Software

        5.5.3. Services

            5.5.3.1. Installation & Integration Services

            5.5.3.2. Maintenance Service

    5.6. Market Size (US$ Million) and Volume Forecast By Component Type, 2022 to 2029

        5.6.1. Instruments

            5.6.1.1. Quantitative Pathology Imaging System

            5.6.1.2. Immunofluorescence Slide Scanner

            5.6.1.3. Multispectral Imaging Systems

            5.6.1.4. Toponome imaging System

        5.6.2. Software

        5.6.3. Services

            5.6.3.1. Installation & Integration Services

            5.6.3.2. Maintenance Service

    5.7. Historical Market Size (US$ Million) Analysis by Imaging Technique, 2012 to 2021

        5.7.1. Immunohistochemistry (IHC) Assay

        5.7.2. Fluorescent In Situ Hybridization (FISH) Assay

        5.7.3. Tissue Microarray (TMA) Assay

    5.8. Market Size (US$ Million) Forecast, by Imaging Technique, 2022 to 2029

        5.8.1. Immunohistochemistry (IHC) Assay

        5.8.2. Fluorescent In Situ Hybridization (FISH) Assay

        5.8.3. Tissue Microarray (TMA) Assay

    5.9. Historical Market Size (US$ Million) Analysis by Application, 2012 to 2021

        5.9.1. Research

        5.9.2. Clinical Diagnostics

    5.10. Market Size (US$ Million) Forecast, by Application, 2022 to 2029

        5.10.1. Research

        5.10.2. Clinical Diagnostics

    5.11. Historical Market Size (US$ Million) Analysis by Application, 2012 to 2021

        5.11.1. Translational Laboratories

        5.11.2. Biopharmaceutical Companies

        5.11.3. Academic Institutes

    5.12. Market Size (US$ Million) Forecast, by Application, 2022 to 2029

        5.12.1. Translational Laboratories

        5.12.2. Biopharmaceutical Companies

        5.12.3. Academic Institutes

    5.13. Drivers and Restraints: Impact Analysis

    5.14. Market Attractiveness Analysis

        5.14.1. By Country

        5.14.2. By Component Type

        5.14.3. By Imaging Technique

        5.14.4. Application

        5.14.5. End User

    5.15. Key Representative Market Presence (Intensity Map)

6. Western Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2029

    6.1. Introduction

    6.2. Regional Market Dynamics

        6.2.1. Drivers

        6.2.2. Restraints

        6.2.3. Trends

    6.3. Historical Market Size (US$ Million) Analysis By Country, 2012 to 2021

        6.3.1. The UK

        6.3.2. Germany

        6.3.3. France

        6.3.4. Italy

        6.3.5. Spain

        6.3.6. Nordics

        6.3.7. BENELUX

        6.3.8. Rest of Western Europe

    6.4. Market Size (US$ Million) Forecast By Country, 2022 to 2029

        6.4.1. The UK

        6.4.2. Germany

        6.4.3. France

        6.4.4. Italy

        6.4.5. Spain

        6.4.6. Nordics

        6.4.7. BENELUX

        6.4.8. Rest of Western Europe

    6.5. Historical Market Size (US$ Million) and Volume Analysis By Component Type, 2012 to 2021

        6.5.1. Instruments

            6.5.1.1. Quantitative Pathology Imaging System

            6.5.1.2. Immunofluorescence Slide Scanner

            6.5.1.3. Multispectral Imaging Systems

            6.5.1.4. Toponome imaging System

        6.5.2. Software

        6.5.3. Services

            6.5.3.1. Installation & Integration Services

            6.5.3.2. Maintenance Service

    6.6. Market Size (US$ Million) and Volume Forecast By Component Type, 2022 to 2029

        6.6.1. Instruments

            6.6.1.1. Quantitative Pathology Imaging System

            6.6.1.2. Immunofluorescence Slide Scanner

            6.6.1.3. Multispectral Imaging Systems

            6.6.1.4. Toponome imaging System

        6.6.2. Software

        6.6.3. Services

            6.6.3.1. Installation & Integration Services

            6.6.3.2. Maintenance Service

    6.7. Historical Market Size (US$ Million) Analysis by Imaging Technique, 2012 to 2021

        6.7.1. Immunohistochemistry (IHC) Assay

        6.7.2. Fluorescent In Situ Hybridization (FISH) Assay

        6.7.3. Tissue Microarray (TMA) Assay

    6.8. Market Size (US$ Million) Forecast, by Imaging Technique, 2022 to 2029

        6.8.1. Immunohistochemistry (IHC) Assay

        6.8.2. Fluorescent In Situ Hybridization (FISH) Assay

        6.8.3. Tissue Microarray (TMA) Assay

    6.9. Historical Market Size (US$ Million) Analysis by Application, 2012 to 2021

        6.9.1. Research

        6.9.2. Clinical Diagnostics

    6.10. Market Size (US$ Million) Forecast, by Application, 2022 to 2029

        6.10.1. Research

        6.10.2. Clinical Diagnostics

    6.11. Historical Market Size (US$ Million) Analysis by Application, 2012 to 2021

        6.11.1. Translational Laboratories

        6.11.2. Biopharmaceutical Companies

        6.11.3. Academic Institutes

    6.12. Market Size (US$ Million) Forecast, by Application, 2022 to 2029

        6.12.1. Translational Laboratories

        6.12.2. Biopharmaceutical Companies

        6.12.3. Academic Institutes

    6.13. Drivers and Restraints: Impact Analysis

    6.14. Market Attractiveness Analysis

        6.14.1. By Country

        6.14.2. By Component Type

        6.14.3. By Imaging Technique

        6.14.4. Application

        6.14.5. End User

    6.15. Key Representative Market Presence (Intensity Map)

7. Eastern Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2029

    7.1. Introduction

    7.2. Historical Market Size (US$ Million) Analysis  By Country, 2012 to 2021

        7.2.1. Russia

        7.2.2. Poland

        7.2.3. Rest of Eastern Europe

    7.3. Market Size (US$ Million) Forecast By Country,2022 to 2029

        7.3.1. Russia

        7.3.2. Poland

        7.3.3. Rest of Eastern Europe

    7.4. Historical Market Size (US$ Million) and Volume Analysis By Component Type, 2012 to 2021

        7.4.1. Instruments

            7.4.1.1. Quantitative Pathology Imaging System

            7.4.1.2. Immunofluorescence Slide Scanner

            7.4.1.3. Multispectral Imaging Systems

            7.4.1.4. Toponome imaging System

        7.4.2. Software

        7.4.3. Services

            7.4.3.1. Installation & Integration Services

            7.4.3.2. Maintenance Service

    7.5. Market Size (US$ Million) and Volume Forecast By Component Type, 2022 to 2029

        7.5.1. Instruments

            7.5.1.1. Quantitative Pathology Imaging System

            7.5.1.2. Immunofluorescence Slide Scanner

            7.5.1.3. Multispectral Imaging Systems

            7.5.1.4. Toponome imaging System

        7.5.2. Software

        7.5.3. Services

            7.5.3.1. Installation & Integration Services

            7.5.3.2. Maintenance Service

    7.6. Historical Market Size (US$ Million) Analysis by Imaging Technique, 2012 to 2021

        7.6.1. Immunohistochemistry (IHC) Assay

        7.6.2. Fluorescent In Situ Hybridization (FISH) Assay

        7.6.3. Tissue Microarray (TMA) Assay

    7.7. Market Size (US$ Million) Forecast, by Imaging Technique, 2022 to 2029

        7.7.1. Immunohistochemistry (IHC) Assay

        7.7.2. Fluorescent In Situ Hybridization (FISH) Assay

        7.7.3. Tissue Microarray (TMA) Assay

    7.8. Historical Market Size (US$ Million) Analysis by Application, 2012 to 2021

        7.8.1. Research

        7.8.2. Clinical Diagnostics

    7.9. Market Size (US$ Million) Forecast, by Application, 2022 to 2029

        7.9.1. Research

        7.9.2. Clinical Diagnostics

    7.10. Historical Market Size (US$ Million) Analysis by Application, 2012 to 2021

        7.10.1. Translational Laboratories

        7.10.2. Biopharmaceutical Companies

        7.10.3. Academic Institutes

    7.11. Market Size (US$ Million) Forecast, by Application, 2022 to 2029

        7.11.1. Translational Laboratories

        7.11.2. Biopharmaceutical Companies

        7.11.3. Academic Institutes

    7.12. Market Attractiveness Analysis

        7.12.1. By Country

        7.12.2. By Component Type

        7.12.3. By Imaging Technique

        7.12.4. Application

        7.12.5. End User

    7.13. Key Representative Market Presence (Intensity Map)

8. Asia-Pacific Excluding Japan (APEJ) Market Analysis 2012 to 2021 and Forecast 2022 to 2029

    8.1. Introduction

    8.2. Regional Market Dynamics

        8.2.1. Drivers

        8.2.2. Restraints

        8.2.3. Trends

    8.3. Historical Market Size (US$ Million) Analysis By Country, 2012 to 2021

        8.3.1. China

        8.3.2. India

        8.3.3. Australia and New Zealand

        8.3.4. ASEAN

        8.3.5. Rest of  APEJ

    8.4. Market Size (US$ Million) Forecast By Country, 2022 to 2029

        8.4.1. China

        8.4.2. India

        8.4.3. Australia and New Zealand

        8.4.4. ASEAN

        8.4.5. Rest of  APEJ

    8.5. Historical Market Size (US$ Million) and Volume Analysis By Component Type, 2012 to 2021

        8.5.1. Instruments

            8.5.1.1. Quantitative Pathology Imaging System

            8.5.1.2. Immunofluorescence Slide Scanner

            8.5.1.3. Multispectral Imaging Systems

            8.5.1.4. Toponome imaging System

        8.5.2. Software

        8.5.3. Services

            8.5.3.1. Installation & Integration Services

            8.5.3.2. Maintenance Service

    8.6. Market Size (US$ Million) and Volume Forecast By Component Type, 2022 to 2029

        8.6.1. Instruments

            8.6.1.1. Quantitative Pathology Imaging System

            8.6.1.2. Immunofluorescence Slide Scanner

            8.6.1.3. Multispectral Imaging Systems

            8.6.1.4. Toponome imaging System

        8.6.2. Software

        8.6.3. Services

            8.6.3.1. Installation & Integration Services

            8.6.3.2. Maintenance Service

    8.7. Historical Market Size (US$ Million) Analysis by Imaging Technique, 2012 to 2021

        8.7.1. Immunohistochemistry (IHC) Assay

        8.7.2. Fluorescent In Situ Hybridization (FISH) Assay

        8.7.3. Tissue Microarray (TMA) Assay

    8.8. Market Size (US$ Million) Forecast, by Imaging Technique, 2022 to 2029

        8.8.1. Immunohistochemistry (IHC) Assay

        8.8.2. Fluorescent In Situ Hybridization (FISH) Assay

        8.8.3. Tissue Microarray (TMA) Assay

    8.9. Historical Market Size (US$ Million) Analysis by Application, 2012 to 2021

        8.9.1. Research

        8.9.2. Clinical Diagnostics

    8.10. Market Size (US$ Million) Forecast, by Application, 2022 to 2029

        8.10.1. Research

        8.10.2. Clinical Diagnostics

    8.11. Historical Market Size (US$ Million) Analysis by Application, 2012 to 2021

        8.11.1. Translational Laboratories

        8.11.2. Biopharmaceutical Companies

        8.11.3. Academic Institutes

    8.12. Market Size (US$ Million) Forecast, by Application, 2022 to 2029

        8.12.1. Translational Laboratories

        8.12.2. Biopharmaceutical Companies

        8.12.3. Academic Institutes

    8.13. Drivers and Restraints: Impact Analysis

    8.14. Market Attractiveness Analysis

        8.14.1. By Country

        8.14.2. By Component Type

        8.14.3. By Imaging Technique

        8.14.4. Application

        8.14.5. End User

    8.15. Key Representative Market Presence (Intensity Map)

9. Japan Market Analysis 2012 to 2021 and Forecast 2022 to 2029

    9.1. Introduction

    9.2. Historical Market Size (US$ Million) and Volume Analysis By Component Type, 2012 to 2021

        9.2.1. Instruments

            9.2.1.1. Quantitative Pathology Imaging System

            9.2.1.2. Immunofluorescence Slide Scanner

            9.2.1.3. Multispectral Imaging Systems

            9.2.1.4. Toponome imaging System

        9.2.2. Software

        9.2.3. Services

            9.2.3.1. Installation & Integration Services

            9.2.3.2. Maintenance Service

    9.3. Market Size (US$ Million) and Volume Forecast By Component Type, 2022 to 2029

        9.3.1. Instruments

            9.3.1.1. Quantitative Pathology Imaging System

            9.3.1.2. Immunofluorescence Slide Scanner

            9.3.1.3. Multispectral Imaging Systems

            9.3.1.4. Toponome imaging System

        9.3.2. Software

        9.3.3. Services

            9.3.3.1. Installation & Integration Services

            9.3.3.2. Maintenance Service

    9.4. Historical Market Size (US$ Million) Analysis by Imaging Technique, 2012 to 2021

        9.4.1. Immunohistochemistry (IHC) Assay

        9.4.2. Fluorescent In Situ Hybridization (FISH) Assay

        9.4.3. Tissue Microarray (TMA) Assay

    9.5. Market Size (US$ Million) Forecast, by Imaging Technique, 2022 to 2029

        9.5.1. Immunohistochemistry (IHC) Assay

        9.5.2. Fluorescent In Situ Hybridization (FISH) Assay

        9.5.3. Tissue Microarray (TMA) Assay

    9.6. Historical Market Size (US$ Million) Analysis by Application, 2012 to 2021

        9.6.1. Research

        9.6.2. Clinical Diagnostics

    9.7. Market Size (US$ Million) Forecast, by Application, 2022 to 2029

        9.7.1. Research

        9.7.2. Clinical Diagnostics

    9.8. Historical Market Size (US$ Million) Analysis by Application, 2012 to 2021

        9.8.1. Translational Laboratories

        9.8.2. Biopharmaceutical Companies

        9.8.3. Academic Institutes

    9.9. Market Size (US$ Million) Forecast, by Application, 2022 to 2029

        9.9.1. Translational Laboratories

        9.9.2. Biopharmaceutical Companies

        9.9.3. Academic Institutes

    9.10. Market Attractiveness Analysis

        9.10.1. By Component Type

        9.10.2. By Imaging Technique

        9.10.3. Application

        9.10.4. End User

    9.11. Key Representative Market Presence (Intensity Map)

10. Middle East and Africa Market Analysis 2012 to 2021 and Forecast 2022 to 2029

    10.1. Introduction

    10.2. Regional Market Dynamics

        10.2.1. Drivers

        10.2.2. Restraints

        10.2.3. Trends

    10.3. Historical Market Size (US$ Million) Analysis By Country, 2012 to 2021

        10.3.1. GCC Countries

        10.3.2. South Africa

        10.3.3. Rest of MEA

    10.4. Market Size (US$ Million) Forecast By Country, 2022-2029

        10.4.1. GCC Countries

        10.4.2. South Africa

        10.4.3. Rest of MEA

    10.5. Historical Market Size (US$ Million) and Volume Analysis By Component Type, 2012 to 2021

        10.5.1. Instruments

            10.5.1.1. Quantitative Pathology Imaging System

            10.5.1.2. Immunofluorescence Slide Scanner

            10.5.1.3. Multispectral Imaging Systems

            10.5.1.4. Toponome imaging System

        10.5.2. Software

        10.5.3. Services

            10.5.3.1. Installation & Integration Services

            10.5.3.2. Maintenance Service

    10.6. Market Size (US$ Million) and Volume Forecast By Component Type, 2022 to 2029

        10.6.1. Instruments

            10.6.1.1. Quantitative Pathology Imaging System

            10.6.1.2. Immunofluorescence Slide Scanner

            10.6.1.3. Multispectral Imaging Systems

            10.6.1.4. Toponome imaging System

        10.6.2. Software

        10.6.3. Services

            10.6.3.1. Installation & Integration Services

            10.6.3.2. Maintenance Service

    10.7. Historical Market Size (US$ Million) Analysis by Imaging Technique, 2012 to 2021

        10.7.1. Immunohistochemistry (IHC) Assay

        10.7.2. Fluorescent In Situ Hybridization (FISH) Assay

        10.7.3. Tissue Microarray (TMA) Assay

    10.8. Market Size (US$ Million) Forecast, by Imaging Technique, 2022 to 2029

        10.8.1. Immunohistochemistry (IHC) Assay

        10.8.2. Fluorescent In Situ Hybridization (FISH) Assay

        10.8.3. Tissue Microarray (TMA) Assay

    10.9. Historical Market Size (US$ Million) Analysis by Application, 2012 to 2021

        10.9.1. Research

        10.9.2. Clinical Diagnostics

    10.10. Market Size (US$ Million) Forecast, by Application, 2022 to 2029

        10.10.1. Research

        10.10.2. Clinical Diagnostics

    10.11. Historical Market Size (US$ Million) Analysis by Application, 2012 to 2021

        10.11.1. Translational Laboratories

        10.11.2. Biopharmaceutical Companies

        10.11.3. Academic Institutes

    10.12. Market Size (US$ Million) Forecast, by Application, 2022 to 2029

        10.12.1. Translational Laboratories

        10.12.2. Biopharmaceutical Companies

        10.12.3. Academic Institutes

    10.13. Drivers and Restraints: Impact Analysis

    10.14. Market Attractiveness Analysis

        10.14.1. By Country

        10.14.2. By Component Type

        10.14.3. By Imaging Technique

        10.14.4. Application

        10.14.5. End User

    10.15. Key Representative Market Presence (Intensity Map)

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Landscape

    13.1. Competition Dashboard

    13.2. Company Share Analysis

    13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments, and SWOT Analysis)

        13.3.1. Perkin Elmer, Inc.

        13.3.2. Bio-Rad Laboratories Inc.

        13.3.3. Thermo Fisher Scientific, Inc.

        13.3.4. Abcam plc.

        13.3.5. Merck KGaA

        13.3.6. Illumina Inc.

        13.3.7. Leica Biosystems Nussloch GmbH

        13.3.8. Ventana Medical Systems, Inc.

        13.3.9. Aushon BioSystems Ltd.

        13.3.10. MicroConstants, Inc.

        13.3.11. ToposNomos Ltd.

14. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2029, By Region

    14.1. Introduction / Key Findings

    14.2. Historical Market Size (US$ Million) Analysis By Region, 2012 to 2021

        14.2.1. North America

        14.2.2. Latin America

        14.2.3. Western Europe

        14.2.4. Eastern Europe

        14.2.5. Asia Pacific Excluding Japan

        14.2.6. Japan

        14.2.7. Middle East & Africa (MEA)

    14.3. Market Size (US$ Million) Forecast By Region, 2022 to 2029

        14.3.1. North America

        14.3.2. Latin America

        14.3.3. Western Europe

        14.3.4. Eastern Europe

        14.3.5. Asia Pacific Excluding Japan

        14.3.6. Japan

        14.3.7. Middle East and Africa

    14.4. Market Attractiveness Analysis By Region

15. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2029, By Component Type

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) and Volume Analysis By Component Type, 2012 to 2021

        15.2.1. Instruments

            15.2.1.1. Quantitative Pathology Imaging System

            15.2.1.2. Immunofluorescence Slide Scanner

            15.2.1.3. Multispectral Imaging Systems

            15.2.1.4. Toponome imaging System

        15.2.2. Software

        15.2.3. Services

            15.2.3.1. Installation & Integration Services

        15.2.4. Maintenance Service

    15.3. Market Size (US$ Million) and Volume Forecast By Component Type,2022 to 2029

        15.3.1. Instruments

            15.3.1.1. Quantitative Pathology Imaging System

            15.3.1.2. Immunofluorescence Slide Scanner

            15.3.1.3. Multispectral Imaging Systems

            15.3.1.4. Toponome imaging System

        15.3.2. Software

        15.3.3. Services

            15.3.3.1. Installation & Integration Services

        15.3.4. Maintenance Service

    15.4. Market Attractiveness Analysis by Component Type

16. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2029, By Imaging Technique

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) Analysis, by Imaging Technique, 2012 to 2021

        16.2.1. Immunohistochemistry (IHC) Assay

        16.2.2. Fluorescent In Situ Hybridization (FISH) Assay

        16.2.3. Tissue Microarray (TMA) Assay

    16.3. Market Size (US$ Million) Forecast, by Imaging Technique, 2022 to 2029

        16.3.1. Immunohistochemistry (IHC) Assay

        16.3.2. Fluorescent In Situ Hybridization (FISH) Assay

        16.3.3. Tissue Microarray (TMA) Assay

    16.4. Market Attractiveness Analysis by Imaging Technique 

17. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2029, By Application

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) Analysis, by Application, 2012 to 2021

        17.2.1. Research

        17.2.2. Clinical Diagnostics

    17.3. Market Size (US$ Million) Forecast, by Application, 2022 to 2029

        17.3.1. Research

        17.3.2. Clinical Diagnostics

    17.4. Market Attractiveness Analysis by Application

18. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2029, By End User

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) Analysis, by End User, 2012 to 2021

        18.2.1. Translational Laboratories

        18.2.2. Biopharmaceutical Companies

        18.2.3. Academic Institutes

    18.3. Market Size (US$ Million) Forecast, by End User, 2022 to 2029

        18.3.1. Translational Laboratories

        18.3.2. Biopharmaceutical Companies

        18.3.3. Academic Institutes

    18.4. Market Attractiveness Analysis by End User

19. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2029

    19.1. Market Size and Y-o-Y Growth

    19.2. Absolute $ Opportunity

20. Assumptions and Acronyms Used

21. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 01: CPT Codes for Digital Pathology

Table 02: DPA Regulatory FDA 510(k) List

Table 03: DPA Regulatory FDA 510(k) List

Table 04: North America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Component Type

Table 05: North America Market Volume Analysis 2012 to 2021 and Forecast 2022 to 2029, By Component Type

Table 06: North America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Imaging Technique

Table 07: North America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Application

Table 08: North America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By End User

Table 09: North America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Country

Table 10: North America Participants Presence (Intensity Mapping)

Table 11: Latin America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Component Type

Table 12: Latin America Market Volume Analysis 2012 to 2021 and Forecast 2022 to 2029, By Component Type

Table 13: Latin America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Imaging Technique

Table 14: Latin America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Application

Table 15: Latin America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By End User

Table 16: Latin America Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Country

Table 17: Latin America Participants Presence (Intensity Mapping)

Table 18: Western Europe Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Component Type

Table 19: Western Europe Market Volume Analysis-2012 to 2021 and Forecast 2022 to 2029, By Component Type

Table 20: Western Europe Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Imaging Technique

Table 21: Western Europe Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Application

Table 22: Western Europe Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By End User

Table 23: Western Europe Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Country

Table 24: Western Europe Participants Presence (Intensity Mapping)

Table 25: Eastern Europe Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Component Type

Table 26: Eastern Europe Market Volume Analysis 2012 to 2021 and Forecast 2022 to 2029, By Component Type

Table 27: Eastern Europe Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Imaging Technique

Table 28: Eastern Europe Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Application

Table 29: Eastern Europe Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By End User

Table 30: Eastern Europe Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Country

Table 31: Eastern Europe Participants Presence (Intensity Mapping)

Table 32: APEJ Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Component Type

Table 33: APEJ Market Volume Analysis-2012 to 2021 and Forecast 2022 to 2029, By Component Type

Table 34: APEJ Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Imaging Technique

Table 35: APEJ Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Application

Table 36: APEJ Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By End User

Table 37: APEJ Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Country

Table 38: APEJ Participants Presence (Intensity Mapping)

Table 39: Japan Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Component Type

Table 40: Japan Market Volume Analysis 2012 to 2021 and Forecast 2022 to 2029, By Component Type

Table 41: Japan Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Imaging Technique

Table 42: Japan Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Application

Table 43: Japan Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By End User

Table 44: Japan Participants Presence (Intensity Mapping)

Table 45: MEA Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Component Type

Table 46: MEA Market Volume Analysis-2012 to 2021 and Forecast 2022 to 2029, By Component Type

Table 47: MEA Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Imaging Technique

Table 48: MEA Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Application

Table 49: MEA Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By End User

Table 50: MEA Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Country

Table 51: MEA Participants Presence (Intensity Mapping)

Table 52:  Global Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Region

Table 53: Global Market Value (US$ Million) Analysis-2012 to 2021 and Forecast 2022 to 2029, By Component Type

Table 54: Global Market Volume Analysis 2012 to 2021 and Forecast 2022 to 2029, By Component Type

Table 55: Global Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Imaging Technique

Table 56: Global Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By Application

Table 57: Global Market Value (US$ Million) Analysis 2012 to 2021 and Forecast 2022 to 2029, By End User
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 01: The USA FDA Regulatory Approval for Medical Devices

Figure 02: Europe Regulatory Approval for Medical Devices

Figure 03: Japan Regulatory Approval for Medical Devices

Figure 04: North America Market Value Share by Component Type (2022)

Figure 06: North America Market Value Share by Application (2022)

Figure 05: North America Market Value Share by Imaging Technique (2022)

Figure 07: North America Market Value Share by End User (2022)

Figure 08: North America Market Value Share by Country (2022)

Figure 09: North America Historical Market Analysis 2012 to 2021

Figure 10: North America Market Forecast, 2022 to 2029

Figure 11: The USA Historical Market Analysis 2012 to 2021

Figure 12: The USA Market Forecast, 2022 to 2029

Figure 13: Canada Historical Market Analysis 2012 to 2021

Figure 14: Canada Market Forecast, 2022 to 2029

Figure 15: North America Market Attractive Analysis by Component Type, 2022 to 2029

Figure 16: North America Market Attractive Analysis by Imaging Technique, 2022 to 2029

Figure 17: North America Market Attractive Analysis by Application, 2022 to 2029

Figure 18: North America Market Attractive Analysis by End User, 2022 to 2029

Figure 19: North America Market Attractive Analysis by Country, 2022 to 2029

Figure 20: North America - Drivers & Restrains Impact Analysis

Figure 21: Latin America Market Value Share by Component Type (2022)

Figure 23: Latin America Market Value Share by Application (2022)

Figure 22: Latin America Market Value Share by Imaging Technique (2022)

Figure 24: Latin America Market Value Share by End User (2022)

Figure 25: Latin America Market Value Share by Country (2022)

Figure 26: Latin America Historical Market Analysis 2012 to 2021

Figure 27: Latin America Market Forecast, 2022 to 2029

Figure 28: Brazil Historical Market Analysis 2012 to 2021

Figure 29: Brazil Market Forecast, 2022 to 2029

Figure 30: Mexico Historical Market Analysis 2012 to 2021

Figure 31: Mexico Market Forecast, 2022 to 2029

Figure 32: Argentina Historical Market Analysis 2012 to 2021

Figure 33: Argentina Market Forecast, 2022 to 2029

Figure 34: Rest of Latin America Historical Market Analysis 2012 to 2021

Figure 35: Rest of Latin America Market Forecast, 2012 to 2021

Figure 36: Latin America Market Attractive Analysis by Component Type, 2022 to 2029

Figure 37: Latin America Market Attractive Analysis by Imaging Technique, 2022 to 2029

Figure 38: Latin America Market Attractive Analysis by Application, 2022 to 2029

Figure 39: Latin America Market Attractive Analysis by End User, 2022 to 2029

Figure 40: Latin America Market Attractive Analysis by Country, 2022 to 2029

Figure 41: Latin America - Drivers & Restraint Impact Analysis

Figure 42: Western Europe Market Value Share by Component Type (2022)

Figure 44: Western Europe Market Value Share by Application (2022)

Figure 43: Western Europe Market Value Share by Imaging Technique (2022)

Figure 45: Western Europe Market Value Share by End User (2022)

Figure 46: Western Europe Market Value Share by Country (2022)

Figure 47: Western Europe Historical Market Analysis 2012 to 2021

Figure 48: Western Europe Market Forecast, 2022 to 2029

Figure 49: The UK Historical Market Analysis 2012 to 2021

Figure 50: The UK Market Forecast, 2022 to 2029

Figure 51: Germany Historical Market Analysis 2012 to 2021

Figure 52: Germany Market Forecast, 2022 to 2029

Figure 53: France Historical Market Analysis 2012 to 2021

Figure 54: France Market Forecast, 2022 to 2029

Figure 55: Italy Historical Market Analysis 2012 to 2021

Figure 56: Italy Market Forecast, 2022 to 2029

Figure 57: Spain Historical Market Analysis 2012 to 2021

Figure 58: Spain Market Forecast, 2022 to 2029

Figure 59: Nordics Historical Market Analysis 2012 to 2021

Figure 60: Nordics Market Forecast, 2022 to 2029

Figure 61: Benelux Historical Market Analysis 2012 to 2021

Figure 62: Benelux Market Forecast, 2022 to 2029

Figure 63: Rest of Western Europe Historical Market Analysis 2012 to 2021

Figure 64: Rest of Western Europe Market Forecast, 2022 to 2029

Figure 65: Western Europe Market Attractive Analysis by Component Type, 2022 to 2029

Figure 66: Western Europe Market Attractive Analysis by Imaging Technique, 2022 to 2029

Figure 67: Western Europe Market Attractive Analysis by Application, 2022 to 2029

Figure 68: Western Europe Market Attractive Analysis by End User, 2022 to 2029

Figure 69: Western Europe Market Attractive Analysis by Component Type, 2022 to 2029

Figure 70: Europe - Drivers & Restraint Impact Analysis

Figure 70: Eastern Europe Market Value Share by Component Type (2022)

Figure 72: Eastern Europe Market Value Share by Application (2022)

Figure 71: Eastern Europe Market Value Share by Imaging Technique (2022)

Figure 73: Eastern Europe Market Value Share by End User (2022)

Figure 74: Eastern Europe Market Value Share by Country (2022)

Figure 75: Eastern Europe Historical Market Analysis 2012 to 2021

Figure 76: Eastern Europe Market Forecast, 2022 to 2029

Figure 77: Russia Historical Market Analysis 2012 to 2021

Figure 78: Russia Market Forecast, 2022 to 2029

Figure 79: Poland Historical Market Analysis 2012 to 2021

Figure 80: Poland Market Forecast, 2022 to 2029

Figure 81: Rest of Eastern Europe Historical Market Analysis 2012 to 2021

Figure 82: Rest of Eastern Europe Market Forecast, 2022 to 2029

Figure 83: Eastern Europe Market Attractive Analysis by Component Type, 2022 to 2029

Figure 84: Eastern Europe Market Attractive Analysis by Imaging Technique, 2022 to 2029

Figure 85: Eastern Europe Market Attractive Analysis by Application, 2022 to 2029

Figure 86: Eastern Europe Market Attractive Analysis by End User, 2022 to 2029

Figure 87: Eastern Europe Market Attractive Analysis by Component Type, 2022 to 2029

Figure 88: APEJ Market Value Share by Component Type (2022)

Figure 90: APEJ Market Value Share by Application (2022)

Figure 89: APEJ Market Value Share by Imaging Technique (2022)

Figure 91: APEJ Market Value Share by End User (2022)

Figure 92: APEJ Market Value Share by Country (2022)

Figure 93: APEJ Historical Market Analysis 2012 to 2021

Figure 94: APEJ Market Forecast, 2022 to 2029

Figure 95: China Historical Market Analysis 2012 to 2021

Figure 96: China Market Forecast, 2022 to 2029

Figure 97: India Historical Market Analysis 2012 to 2021

Figure 98: India Market Forecast, 2022 to 2029

Figure 99: Australia and NZ Historical Market Analysis 2012 to 2021

Figure 100: Australia and NZ Market Forecast, 2022 to 2029

Figure 101: ASEAN Historical Market Analysis 2012 to 2021

Figure 102: ASEAN Market Forecast, 2022 to 2029

Figure 103: Rest of APEJ Historical Market Analysis 2012 to 2021

Figure 104: Rest of APEJ Market Forecast, 2022 to 2029

Figure 105: APEJ Market Attractive Analysis by Component Type, 2022 to 2029

Figure 106: APEJ Market Attractive Analysis by Imaging Technique, 2022 to 2029

Figure 107: APEJ Market Attractive Analysis by Application, 2022 to 2029

Figure 108: APEJ Market Attractive Analysis by End User, 2022 to 2029

Figure 109: APEJ Market Attractive Analysis by Component Type, 2022 to 2029

Figure 110: APAC Drivers & Restraint Impact Analysis

Figure 111: Japan Market Value Share by Component Type (2022)

Figure 113: Japan Market Value Share by Application (2022)

Figure 112: Japan Market Value Share by Imaging Technique (2022)

Figure 114: Japan Market Value Share by End User (2022)

Figure 115: Japan Historical Market Analysis 2012 to 2021

Figure 116: Japan Market Forecast, 2022 to 2029

Figure 117: Japan Market Attractive Analysis by Component Type, 2022 to 2029

Figure 118: Japan Market Attractive Analysis by Imaging Technique, 2022 to 2029

Figure 119: Japan Market Attractive Analysis by Application, 2022 to 2029

Figure 120: Japan Market Attractive Analysis by End User, 2022 to 2029

Figure 121: MEA Market Value Share by Component Type (2022)

Figure 123: MEA Market Value Share by Application (2022)

Figure 122: MEA Market Value Share by Imaging Technique (2022)

Figure 124: MEA Market Value Share by End User (2022)

Figure 125: MEA Market Value Share by Country (2022)

Figure 126: MEA Historical Market Analysis 2012 to 2021

Figure 127: MEA Market Forecast, 2022 to 2029

Figure 128: South Africa Historical Market Analysis 2012 to 2021

Figure 129: South Africa Market Forecast, 2022 to 2029

Figure 130: GCC Countries Historical Market Analysis 2012 to 2021

Figure 131: GCC Countries Market Forecast, 2022 to 2029

Figure 132: Rest of MEA Historical Market Analysis 2012 to 2021

Figure 133: Rest of MEA Market Forecast, 2022 to 2029

Figure 134: MEA Market Attractive Analysis by Component Type, 2022 to 2029

Figure 135: MEA Market Attractive Analysis by Imaging Technique, 2022 to 2029

Figure 136: MEA Market Attractive Analysis by Application, 2022 to 2029

Figure 137: MEA Market Attractive Analysis by End User, 2022 to 2029

Figure 138: MEA Market Attractive Analysis by Component Type, 2022 to 2029

Figure 139: MEA Drivers & Restraint Impact Analysis

Figure 140: Global Market Share Analysis

Figure 141: Global Market Attractive Analysis by Region, 2022 to 2029

Figure 142: Global Market Attractive Analysis by Component, 2022 to 2029

Figure 143: Global Market Attractive Analysis by Imaging Techniques, 2022 to 2029

Figure 144: Global Market Attractive Analysis by Application, 2022 to 2029

Figure 145: Global Market Attractive Analysis by End User, 2022 to 2029

Figure 146: Global Historical Market Analysis 2012 to 2021

Figure 147: Global Market Forecast, 2022 to 2029

Figure 148: Global Market Absolute $ Opportunity, 2012 to 2021

Figure 149: Global Market Absolute $ Opportunity, 2022 – 2029

Recommendations

Healthcare

Veterinary Molecular Diagnostics Market

Published : April 2023

Healthcare

PD-L1 Biomarker Testing Market

Published : February 2023

Technology

Human Identification Market

Published : January 2023

Healthcare

Renal Biomarker Market

Published : October 2022

Explore Healthcare Insights

View Reports

Multiplex Biomarker Imaging Market